
News from sanabenefits.com
Top sanabenefits.com News

Ozempic · United StatesThe explosive rise of GLP-1 medications—such as Mounjaro, Ozempic, and Wegovy—has ignited more than just headlines. It has fundamentally shifted how Americans access and pay for medications, driving innovation in affordability models, and fueling a dramatic increase in direct-to-consumer (DTC) healthcare platforms. Originally approved for type 2 diabetes, GLP-1s have surged in popularity due to their effectiveness in treating obesity and other c…See the Story
GLP-1s broke the system
100% Left coverage: 1 sources